Mogamulizumab is safe and possibly effective in HTLV-1-associated myelopathy | 2 Minute Medicine 2 Minute Medicine , 12 Feb 2018 1. In this combined phase 1-2a study, mogamulizumab used for treatment of human T-lymphotropic virus type 1 (HTLV-1) associated…